New once-daily pill could simplify Wilson's disease treatment
Disease control
Not yet recruiting
This study tests a new once-daily version of trientine against the standard drug penicillamine for people newly diagnosed with Wilson's disease, a genetic condition that causes copper buildup. About 38 children (aged 8+) and adults will take one of the two treatments for 48 weeks…
Phase: PHASE3 • Sponsor: Orphalan • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC